Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer’s disease-Reference-Cited by-同舟云学术

Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer’s disease

Published:2017-03-31 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Gameiro Isabel,Michalska Patrycja,Tenti Giammarco,Cores Ángel,Buendia Izaskun,Rojo Ana I.,Georgakopoulos Nikolaos D.,Hernández-Guijo Jesús M.,Teresa Ramos María,Wells Geoffrey,López Manuela G.,Cuadrado Antonio,Menéndez J. Carlos,León Rafael

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep45701.pdf

Reference69 articles.

1. Goedert, M. & Spillantini, M. G. A century of Alzheimer’s disease. Science 314, 777–781, doi: 10.1126/science.1132814 (2006).

2. Holtzman, D. M., Morris, J. C. & Goate, A. M. Alzheimer’s disease: the challenge of the second century. Science translational medicine 3, 77sr71, doi: 10.1126/scitranslmed.3002369 (2011).

3. Mondragon-Rodriguez, S., Perry, G., Luna-Munoz, J., Acevedo-Aquino, M. C. & Williams, S. Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer’s disease and Down syndrome. Neuropathology and applied neurobiology 40, 121–135, doi: 10.1111/nan.12084 (2014).

4. Himmelstein, D. S., Ward, S. M., Lancia, J. K., Patterson, K. R. & Binder, L. I. Tau as a therapeutic target in neurodegenerative disease. Pharmacology & therapeutics 136, 8–22, doi: 10.1016/j.pharmthera.2012.07.001 (2012).

5. Hooper, C., Killick, R. & Lovestone, S. The GSK3 hypothesis of Alzheimer’s disease. Journal of neurochemistry 104, 1433–1439, doi: 10.1111/j.1471-4159.2007.05194.x (2008).

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Norboldine improves cognitive impairment and pathological features in Alzheimer's disease by activating AMPK/GSK3β/Nrf2 signaling pathway;Journal of Ethnopharmacology;2024-10

2. Neuroprotection of isoorientin against microglia activation induced by lipopolysaccharide via regulating GSK3β, NF-κb and Nrf2/HO-1 pathways;Immunopharmacology and Immunotoxicology;2024-09-08

3. The Interplay of Protein Aggregation, Genetics, and Oxidative Stress in Alzheimer’s Disease: Role for Natural Antioxidants and Immunotherapeutics;Antioxidants;2024-07-18

4. Human dental pulp stem cells mitigate the neuropathology and cognitive decline via AKT-GSK3β-Nrf2 pathways in Alzheimer’s disease;International Journal of Oral Science;2024-05-13

5. Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment;Medicinal Research Reviews;2024-04-28